- Home
- IVT vs HRMY Comparison
IVT vs HRMY Comparison
Compare IVT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVT | HRMY |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IVT | HRMY |
|---|---|---|
| Price | $31.58 | $33.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $35.00 | ★ $48.08 |
| AVG Volume (30 Days) | 635.3K | ★ 1.1M |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 647.37 | 7.97 |
| EPS | 0.33 | ★ 2.63 |
| Revenue | $299,169,000.00 | ★ $868,453,000.00 |
| Revenue This Year | $12.43 | $18.17 |
| Revenue Next Year | $6.69 | $13.71 |
| P/E Ratio | $96.55 | ★ $13.09 |
| Revenue Growth | 9.20 | ★ 21.51 |
| 52 Week Low | $27.06 | $25.90 |
| 52 Week High | $37.22 | $43.49 |
Technical Indicators
Market Signals| Indicator | IVT | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 30.59 |
| Support Level | $30.42 | $26.12 |
| Resistance Level | $31.71 | $34.65 |
| Average True Range (ATR) | 0.69 | 1.95 |
| MACD | 0.24 | -0.46 |
| Stochastic Oscillator | 75.96 | 10.86 |
Price Performance
Historical ComparisonAbout IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.